Stocks on the Move: Silicom (NASDAQ:SILC), P.A.M. Transportation Services (NASDAQ:PTSI), CytomX Therapeutics (NASDAQ:CTMX), INSYS Therapeutics (NASDAQ:INSY)

Remark Media, Inc. (NASDAQ:MARK) shares moved up 0.44% in last trading session and ended the day at $4.59. MARK Gross Margin is 96.20% and its has a return on assets of -57.60%. Remark Media, Inc. (NASDAQ:MARK) quarterly performance is 9.03%.

Remark Media, Inc. (NASDAQ:MARK) Management expects to report its full fourth quarter and year-end 2015 results via a press release and conference call during the week of March 28, 2016.

Silicom Ltd. (NASDAQ:SILC) ended the last trading day at $32.10. Company weekly volatility is calculated as 2.31%. Silicom Ltd. (NASDAQ:SILC) showed a weekly performance of 0.44%.

On 9 March, Silicom Ltd. (NASDAQ:SILC) announced that it has received a significant new Design Win from an existing customer, a Tier-1 Cyber Security company, for three versions of Silicom Smart Cards to be deployed in a number of its advanced appliances. Silicom believes that sales generated from this Design Win will ramp up gradually to several million dollars per year.

On 18 March, P.A.M. Transportation Services, Inc. (NASDAQ:PTSI) shares moved up 2.72% and was closed at $30.63. PTSI EPS growth in last 5 year was 28.20%. P.A.M. Transportation Services, Inc. (NASDAQ:PTSI) year to date (YTD) performance is 11.02%.

P.A.M. Transportation Services, Inc. (NASDAQ:PTSI) announced that it is amending its previously announced modified “Dutch auction” tender offer to purchase up to 325,000 shares of its outstanding common stock at a price of not less than $27.00 and not more than $30.00 per share. Under the amended terms, the Company is now offering to purchase up to 425,000 shares of its common stock at a price of not less than $31.00 and not more than $34.00 per share. The Company is also extending the expiration date of the tender offer.

CytomX Therapeutics, Inc. (NASDAQ:CTMX) shares moved up 4.19% in last trading session and ended the day at $12.44. CTMX has a return on assets of -65.10%. CytomX Therapeutics, Inc. (NASDAQ:CTMX) quarterly performance is -39.55%.

CytomX Therapeutics (NASDAQ:CTMX), announced that preclinical results from its Probody therapeutics pipeline will be presented at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2016 from April 16-20 in New Orleans, Louisiana.

INSYS Therapeutics, Inc. (NASDAQ:INSY) caters to the Healthcare space. It has a net profit margin of 17.70% and weekly performance is 6.07%. On the last day of trading company shares ended up at $17.99.

Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until April 4, 2016 to file lead plaintiff applications in a securities class action lawsuit against Insys Therapeutics, Inc. (NASDAQ:INSY), if they purchased the Company’s securities between March 3, 2015 and January 25, 2016, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Arizona.